Comparison of Cy-Atg Vs Cy-Flu-Atg for the Conditioning Therapy in Allo-HCT

NCT00774527 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

82

Enrollment

NETWORK

Sponsor class

Conditions

Bone Marrow Failure Syndromes

Interventions

DRUG: Cyclophosphamide-fludarabine-anti thymocyte globulin

Sponsor

Cooperative Study Group A for Hematology